Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 10/20 | 0.57 |
| ▸ | KDR | P35968 | 10/20 | 0.57 |
| ▸ | EGFR | P00533 | 3/20 | 0.57 |
| ▸ | ABL1 | P00519 | 2/20 | 0.57 |
| ▸ | ABL2 | P42684 | 2/20 | 0.57 |
| ▸ | LCK | P06239 | 10/20 | 0.56 |
| ▸ | TEK | Q02763 | 10/20 | 0.56 |
| ▸ | RIPK2 | O43353 | 2/20 | 0.53 |
| ▸ | EIF2AK3 | Q9NZJ5 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22676745 | 0.91 | SRC (0.67) | SRCKDREGFRABL1ABL2 | |
| SCHEMBL18044717 | 0.82 | KDR (0.59) | SRCKDREGFRABL1ABL2 | |
| SCHEMBL7005521 | 0.82 | LCK (0.72) | SRCKDREGFRABL1ABL2 | |
| SCHEMBL22418477 | 0.80 | TEK (0.52) | SRCKDREGFRABL1ABL2 | |
| SCHEMBL23917434 | 0.80 | SRC (0.61) | SRCKDREGFRABL1ABL2 | |
| SCHEMBL26110170 | 0.80 | AXL (0.63) | SRCKDREGFRABL1ABL2 | |
| SCHEMBL13020096 | 0.80 | SRC (0.69) | SRCKDREGFRABL1ABL2 | |
| SCHEMBL30582589 | 0.80 | AXL (0.63) | SRCKDREGFRABL1ABL2 | |
| SCHEMBL16202367 | 0.79 | SRC (0.67) | SRCKDREGFRABL1ABL2 | |
| SCHEMBL5016910 | 0.78 | PIK3CD (0.65) | SRCKDREGFRABL1ABL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4499616-A1 | SPIROBICYCLIC COMPOUNDS | Acerand Therapeutics (Hong Kong) Limited (HK) | 2025-02-05 | — | — | EP | disclosed |
| WO-2023192502-A1 | SPIROBICYCLIC COMPOUNDS | ACERAND THERAPEUTICS (USA) LIMITED (US) | 2023-10-05 | — | — | WO | disclosed |